Hongrie - Clinical research services in support of Phase I-IV drug and device development
The Hungarian SME provides pharmaceutical, biotechnology and medical device companies with a broad range of clinical research services in support of Phase I-IV drug and device development, including project management, clinical monitoring, scientific and medical support, investigator and patient recruitment. The SME is offering their subcontracting/outsourcing activities concerning to all type of clinical trials.
The Hungarian SME - has expertise in a wide range of therapeutic areas, including oncology, cardiovascular, central nervous system, gynecology, dermatology, respiratory and allergy/immunology; - combines the advantages of a regional CRO - cost effectiveness, local knowledge, personal service, flexibility - with the expertise and understanding that comes from a history of managing global clinical trials to the highest quality standards throughout the world; - high standard of quality, value and performance maintained by a proactive quality assurance model based on redundant data and process review that incorporates documented internal monitoring, client surveys and feedback, and outside auditing; - activities are strictly based on ICH-GCP guidelines, EU directives, local legislation and ethical principles.
The foreign partner should be interested in the R&D with limited access of treatment naive patients in CEE region. The foreign partner's product pipeline is in pre-clinical and Phase I-II stage and plan to initiate in the near future new Phase I / III trials.